Concepedia

Edward F. McClay

EF

Statistics

Publications

39

Citations

1.8K

H-Index

25

Active since

1987

Affiliations

University of California San Diego(Current)

California Cancer Associates for Research and Excellence

Merck KGaA, Darmstadt (Germany)

Ono Pharmaceutical (United States)

Northern California Melanoma Center

Edward F. McClay is an author at University of California San Diego specializing in oncology, medicine, and pharmacology.

Publications per year

1987–2023

39

Publications

39

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho et al. · Journal for ImmunoTherapy of Cancer · 2020 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian Cancer

Saeeda Kirmani, Patricia S. Braly, Edward F. McClay et al. · Gynecologic Oncology · 1994 · 111 citations

Medicine, Gynecology, Oncology +13

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.

Edward F. McClay, Michael J. Mastrangelo, Robert E. Bellet et al. · PubMed · 1987 · 97 citations

Medicine, Oncology, Pharmacology +15

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 39